RxDoctor Payments Data

Michael Shiekh

Psychiatry · Dallas, TXNPI 1386863397

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Johnson & Johnson at 25.2% of the total. 2025 is the largest year on record at $429, 2.8 times the $152 reported in 2019.

$1,560in general payments, 2019–2025

Across 73 payments — averaging $21.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$394
  • Takeda Pharmaceuticals U.S.A., Inc.$182
  • AbbVie$175
  • Otsuka America Pharmaceutical, Inc.$152
  • Sunovion Pharmaceuticals Inc.$150
  • MDD US Operations, LLC$105
  • plus $403 from 10 others
$163,594in research payments, 2019–2025

Across 32 payments — averaging $5112.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Supernus Pharmaceuticals, Inc.$109K
  • AbbVie$55K

What the payments were for

  • Food & beverage$1,560100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,560 in reported general payments places this provider in the 75th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,522
Gabapentin12$602
Escitalopram Oxalate29$466
Bupropion XlBupropion Hcl19$240
Clonazepam33$239
Trazodone Hcl23$234
Alprazolam ErAlprazolam16$210
Alprazolam35$199
Duloxetine Hcl16$125
Diazepam16$84
Lamotrigine11$73
Zolpidem Tartrate ErZolpidem Tartrate12$43
Temazepam12$23
Amitriptyline Hcl12$21

Paid to pharmacies, not to this prescriber.

Other psychiatry in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →